CODX
Co-Diagnostics, Inc.
There isn't enough reported data to score CODX yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CODX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
CODX's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CODX PE Valuation
CODX has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CODX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect CODX's losses to shrink, with revenue growing.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CODX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$22.88 | +$6.82 |
| Q2 2026 | -$26.67 | +$7.83 |
| Q1 2026 | -$32.11 | +$2.99 |
| Q4 2025 | -$35.25 | +$1.95 |
| Q3 2025 | -$29.70 | +$11.40 |
| Q2 2025 | -$34.50 | +$3.00 |
| Q1 2025 | -$35.10 | +$4.20 |
| Q4 2024 | -$37.20 | -$1.20 |
CODX has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
CODX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $282.9K | +95% |
| Q2 2026 | $166.1K | +2% |
| Q1 2026 | $146K | +190% |
| Q4 2025 | $263.9K | +77% |
| Q3 2025 | $145.4K | -77% |
| Q2 2025 | $162.9K | -94% |
| Q1 2025 | $50.3K | -89% |
| Q4 2024 | $149.3K | -96% |
CODX's revenue is recovering but still below its 2021 peak: $282,881 last quarter, up 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2216% | +2608 points |
| Q2 2026 | -3732% | +1214 points |
| Q1 2026 | -6309% | +10701 points |
| Q4 2025 | -10057% | -2083 points |
| Q3 2025 | -4824% | -3228 points |
| Q2 2025 | -4946% | -4657 points |
| Q1 2025 | -17010% | -14817 points |
| Q4 2024 | -7974% | -7641 points |
CODX's operating margin was −2216% last quarter, up 2608 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over CODX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over CODX on profitability, with a higher operating margin.
CODX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.7M | +$280.7K |
| Q2 2026 | -$7.2M | +$1.5M |
| Q1 2026 | -$8M | +$848.8K |
| Q4 2025 | -$6.3M | +$2M |
| Q3 2025 | -$6M | +$1.4M |
| Q2 2025 | -$8.7M | -$3.4M |
| Q1 2025 | -$8.8M | +$55.5K |
| Q4 2024 | -$8.3M | -$3.1M |
CODX has burned cash in most quarters: −$27M over the past year, against −$32M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CODX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CODX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +46% | +2M shares |
| 1 year | +468% | +5.2M shares |
| 3 years | +547% | +5.3M shares |
| 5 years | +533% | +5.3M shares |
| Available history | +725% | +5.5M shares |
CODX has 6M diluted shares, up 468% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $159,673 |
| Q3 2023 | $166,326 |
| Q2 2023 | $555,734 |
| Q1 2023 | $482,196 |
| Q4 2022 | $1.2M |
| Q3 2022 | $10.4M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CODX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CODX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -7.7x | Net Cash |
| Q2 2022 | -2.8x | Net Cash |
| Q1 2022 | -2.1x | Net Cash |
| Q4 2021 | -1.9x | Net Cash |
| Q3 2021 | -1.6x | Net Cash |
| Q2 2021 | -1.4x | Net Cash |
| Q1 2021 | -1.1x | Net Cash |
| Q4 2020 | -1.0x | Net Cash |
CODX has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CODX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 0.9 | Oversold |
CODX's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CODX PE vs Healthcare Sector
| Metric | CODX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CODX has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CODX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.67 | 60% below |
| 20 week MA | $1.28 | 79% below |
| 50 week MA | $2.84 | 90% below |
| 100 week MA | $7.77 | 97% below |
| 200 week MA | $24.5 | 99% below |
CODX is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CODX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.8 | $325.2 | +1069% |
| 2021 | $325.2 | $282.3 | -13% |
| 2022 | $282.3 | $76.5 | -73% |
| 2023 | $76.5 | $39.9 | -48% |
| 2024 | $39.9 | $21.9 | -45% |
| 2025 | $21.9 | $7.05 | -68% |
| 2026 YTD | $7.05 | $0.27 | -96% |
CODX has finished five years in a row lower, and it's down 96% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over CODX on returns for 2026, with the stronger performance.